Trials / Terminated
TerminatedNCT02978833
Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy
Ultrasound-Guided Platelet Rich Plasma Versus Whole Blood Injection for the Treatment of Gluteus Medius Tendinopathy: A Double-Blind Randomized Controlled Study
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Hospital for Special Surgery, New York · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Gluteus medius tendinopathy, which is often referred to as Greater Trochanteric Pain Syndrome, is characterized by pain in the lateral aspect of the hip that is aggravated by side lying, stair climbing, and walking. Treatment is currently limited to lifestyle modifications, corticosteroid injections, physical therapy, and open and endoscopic surgical repair. Platelet rich plasma (PRP) injections contain important growth factors that are essential in the healing and tissue formation processes. However, the extent to which PRP is more efficacious than whole blood in tendinopathy remains unclear. In this double-blind randomized trial, patients will be allocated to receive either a PRP or whole-blood injection. Post-procedure assessments will occur at 6 weeks, 3 months, 6 months, 9 months, and 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | PRP | |
| BIOLOGICAL | Whole Blood | |
| DEVICE | Ultrasound |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-12-01
- Last updated
- 2018-08-07
- Results posted
- 2018-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02978833. Inclusion in this directory is not an endorsement.